Eupharlaw is pleased to announce the partnership agreement with AKRN Scientific Consulting

In the 20th Eupharlaw’s anniversary we celebrate our new collaboration with ÅKRN Scientific Consulting

Since our beginnings, dedicated to European Pharmaceutical Law, we have provided advice to pharmaceutical and the technology and medical devices industries, but given the important changes that the application of Regulation (EU) 745/2017 and Regulation (EU) 746/2017 will mean for the sector, we decided to strengthen our legal advice with specialized technical collaborators by product category.

Pharmaceutical Law embraces the regulatory and legal contents that affect research, development, manufacture, authorization, financing, marketing, prescription, dispensing, and any other aspect of the life cycle of the medicine or medical device.

AKRN SC is a clinical research and regulatory consulting firm for medical devices (MD) and in-vitro devices (IVD), based in Spain and Sweden, we are joining with to complement our specialised legal advice on pharmaceutical law with scientific services for our clients.

They have a long experience providing clinical development services on a stand-alone basis, or as part of an integrated full-service solution together with their European CRO-partners.

The Clinical Research Sector is a highly regulated area of ​​high innovation; therefore, it requires a demanding legal-technical specialization.

Our two companies share a passion for providing optimized services tailored to our clients and MedTech partners.